T. Rowe Price Health Sciences has the expertise and structure it needs to add value in this rapidly evolving market segment, resulting in a Morningstar Analyst Rating of Silver.
- NAV / 1-Day Return 90.39 / 0.38 %
- Total Assets 16.2 Bil
Adj. Expense Ratio
- Expense Ratio 0.750%
- Distribution Fee Level Low
- Share Class Type No Load
- Category Health
- Investment Style Large Growth
- Min. Initial Investment 2,500
- Status Open
- TTM Yield 0.00
- Turnover 34%
Morningstar’s Analysis PRHSX
Will PRHSX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.